JYLAMVO vs VYLOY

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. JYLAMVO and VYLOY are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	JYLAMVO	VYLOY
Rating	New	72/100
Pharmacy pays	~$4.92 /30	—
Type	RX	RX
Active ingredient	METHOTREXATE	ZOLBETUXIMAB-CLZB
Manufacturer	Shorla	Astellas
Dosage forms	Solution	Injectable
Drug class	Folate Analog Metabolic Inhibitor	—
Boxed warning	Boxed warning	None
Half-life	about 3 to 10 hours	—
Treats	Juvenile Arthritis, Rheumatoid Arthritis, Breast Neoplasms	Adenocarcinoma, Esophageal Neoplasms

jylamvo vyloy

Rating

New

72/100

Pharmacy pays

~$4.92 /30

—

Type

Active ingredient

METHOTREXATE

ZOLBETUXIMAB-CLZB

Manufacturer

Shorla

Astellas

Dosage forms

Solution

Injectable

Drug class

Folate Analog Metabolic Inhibitor

—

Boxed warning

None

Half-life

about 3 to 10 hours

—

Treats

Juvenile Arthritis, Rheumatoid Arthritis, Breast Neoplasms

Adenocarcinoma, Esophageal Neoplasms

Frequently asked questions

What is the difference between Jylamvo and Vyloy?

Jylamvo contains Methotrexate, while Vyloy contains Zolbetuximab-Clzb — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.